The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Melatonin Pharma Nord 3 mg film-coated tablets

Pharma Nord ApSPA1242/002/001

Main Information

Trade NameMelatonin Pharma Nord 3 mg film-coated tablets
Active SubstancesMelatonin
Dosage FormFilm-coated tablet
Licence HolderPharma Nord ApS
Licence NumberPA1242/002/001

Group Information

ATC CodeN05CH01 melatonin


License statusAuthorised
Licence Issued15/11/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back